To The Moon

Bioline RX Ltd Sponsored ADR (BLRX) has released an update. BiolineRx Ltd., an Israeli company, has successfully completed a registered direct offe...

BioLineRx Ltd. Q4 2023 Earnings Call Transcript March 26, 2024 BioLineRx Ltd. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (. Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Fourth Quarter and Full Year 2023 Financial Results Conference Call. All participants are presently in a listen-only mode. Following management’s formal presentation, instructions will be given for the question-and-answer session. I would now like to turn the call over to John Lacey, Head of Investor Relations and Corporate Communications. John, please go ahead.Since FDA approval in September and the subsequent launch of APHEXDA in U.S. in Q4 early signs among payers and top tier stem cell transplant centers suggest that the APHEXDA value proposition is resonating very well and evolving the stem cell mobilization treatment paradigm for patients with multiple myeloma. Recall that a key consideration when we elected to commercialize APH

Nio may be a trendy investment, but there are better EV stock picks available.

These industry-leading businesses need to be on your radar as potential long-term investments.

Alibaba stock was muted despite a move from China’s central bank to boost consumption. Dreamstime The stock market doesn’t believe that the latest stimulus from China will b

Bionano Genomics has effected a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-10, effective after the market close on August 4, 2023.The Company’s common stock will begin trading on a split-adjusted basis commencing upon market open onAugust 7, 2023. BNGO is -11.6% to $0.5201

In a report released today, Andrew Boone from JMP Securities maintained a Buy rating on Alphabet Class A (GOOGL – Research Report), with a price ta...

May 9 (Reuters) - Tonix Pharmaceuticals Holding Corp: * TONIX PHARMACEUTICALS ANNOUNCES 1-FOR-6.25

By Josh Beckerman Shares of Tonix Pharmaceuticals Holding fell 20% to 41 cents on Tuesday a

SAN DIEGO, May 01, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), today announced that on